PubMed

Premarket Clinical Evidence Strength and Recalls of High-Risk Therapeutic Medical Devices.

PMID: 42566203 · 2026-08-07

M, a, r, y, a, m, , M, o, o, g, h, a, l, i, ;, , F, a, a, i, z, a, h, , A, r, s, h, a, d, ;, , V, i, n, a, y, , K, , R, a, t, h, i, ;, , K, u, s, h, a, l, , T, , K, a, d, a, k, i, a, ;, , A, l, e, x, a, n, d, e, r, , O, , E, v, e, r, h, a, r, t, ;, , J, o, s, e, p, h, , S, , R, o, s, s, ;, , S, a, n, k, e, t, , S, , D, h, r, u, v, a

학술지JAMA health forum

연도2026-08-07

PMID42566203

초록

High-risk medical devices approved through the US Food and Drug Administration (FDA) premarket approval (PMA) pathway may be supported by limited premarket clinical evidence, leaving uncertainties about safety. Whether device, premarket clinical evidence, or regulatory characteristics are associated with subsequent device recalls is unknown. To examine the association between device, premarket clinical evidence, and regulatory characteristics and serious recalls among high-risk therapeutic devic

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.